financetom
Business
financetom
/
Business
/
Market Chatter: Qualcomm to Pay $75 Million to Settle Lawsuit Over Sales, Licensing Practices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Qualcomm to Pay $75 Million to Settle Lawsuit Over Sales, Licensing Practices
Jun 18, 2024 3:08 PM

05:54 PM EDT, 06/18/2024 (MT Newswires) -- Qualcomm ( QCOM ) agreed to pay $75 million to resolve a shareholder lawsuit over allegations of fraud and anticompetitive sales and licensing practices, Reuters reported Tuesday, citing a preliminary all-cash settlement filed with the federal court in San Diego.

The accord requires approval by US District Judge Jinsook Ohta, who certified the suit as a class action in March 2023, according to the report.

Qualcomm ( QCOM ) and six individual defendants, including Paul Jacobs and Steven Mollenkopf, the former chief executive officers, agreed to settle but denied wrongdoing, the report said.

The company didn't immediately respond to a request for comment, Reuters said.

Qualcomm ( QCOM ) didn't immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 227.65, Change: +0.56, Percent Change: +0.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Nuvation Bio Stock Trading Halted, Pending Material News Release
--Nuvation Bio Stock Trading Halted, Pending Material News Release
Jun 11, 2025
01:06 PM EDT, 06/11/2025 (MT Newswires) -- Price: 2.37, Change: -0.16, Percent Change: -6.32 ...
US FDA approves Nuvation Bio's lung cancer therapy
US FDA approves Nuvation Bio's lung cancer therapy
Jun 11, 2025
June 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's ( NUVB ) therapy for patients with a type of lung cancer. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli) ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Kazia Therapeutics (KZIA) Stock Surges 77% On Positive Preclinical Data For Breast Cancer Drug
Kazia Therapeutics (KZIA) Stock Surges 77% On Positive Preclinical Data For Breast Cancer Drug
Jun 11, 2025
Shares of Kazia Therapeutics Ltd ( KZIA ) are surging Wednesday following the announcement of preclinical research findings for its lead drug candidate, paxalisib. What To Know: The clinical-stage biotechnology revealed data published in the peer-reviewed journal Molecular Cancer Therapeutics highlighting paxalisib’s potential in treating triple-negative breast cancer. The research, conducted at the QIMR Berghofer Medical Research Institute, demonstrated that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved